1. Home
  2. FUTU vs LIMNW Comparison

FUTU vs LIMNW Comparison

Compare FUTU & LIMNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUTU
  • LIMNW
  • Stock Information
  • Founded
  • FUTU 2011
  • LIMNW N/A
  • Country
  • FUTU Hong Kong
  • LIMNW United States
  • Employees
  • FUTU N/A
  • LIMNW N/A
  • Industry
  • FUTU Investment Bankers/Brokers/Service
  • LIMNW
  • Sector
  • FUTU Finance
  • LIMNW
  • Exchange
  • FUTU Nasdaq
  • LIMNW Nasdaq
  • Market Cap
  • FUTU N/A
  • LIMNW N/A
  • IPO Year
  • FUTU 2019
  • LIMNW N/A
  • Fundamental
  • Price
  • FUTU $163.61
  • LIMNW $0.35
  • Analyst Decision
  • FUTU Strong Buy
  • LIMNW
  • Analyst Count
  • FUTU 5
  • LIMNW 0
  • Target Price
  • FUTU $160.38
  • LIMNW N/A
  • AVG Volume (30 Days)
  • FUTU 2.7M
  • LIMNW N/A
  • Earning Date
  • FUTU 08-19-2025
  • LIMNW N/A
  • Dividend Yield
  • FUTU 1.19%
  • LIMNW N/A
  • EPS Growth
  • FUTU 58.31
  • LIMNW N/A
  • EPS
  • FUTU 6.00
  • LIMNW N/A
  • Revenue
  • FUTU $1,788,948,850.00
  • LIMNW N/A
  • Revenue This Year
  • FUTU $48.97
  • LIMNW N/A
  • Revenue Next Year
  • FUTU $10.24
  • LIMNW N/A
  • P/E Ratio
  • FUTU $27.79
  • LIMNW N/A
  • Revenue Growth
  • FUTU 54.51
  • LIMNW N/A
  • 52 Week Low
  • FUTU $51.80
  • LIMNW N/A
  • 52 Week High
  • FUTU $174.36
  • LIMNW N/A
  • Technical
  • Relative Strength Index (RSI)
  • FUTU 72.39
  • LIMNW N/A
  • Support Level
  • FUTU $155.52
  • LIMNW N/A
  • Resistance Level
  • FUTU $174.36
  • LIMNW N/A
  • Average True Range (ATR)
  • FUTU 7.36
  • LIMNW 0.00
  • MACD
  • FUTU 1.72
  • LIMNW 0.00
  • Stochastic Oscillator
  • FUTU 77.05
  • LIMNW 0.00

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: